Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Work In Process (2018 - 2026)

TransMedics has reported Work In Process over the past 8 years, most recently at $2.0 million for Q4 2025.

  • For Q4 2025, Work In Process fell 38.73% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, down 38.73%, while the annual FY2025 figure was $2.0 million, 38.73% down from the prior year.
  • Work In Process for Q4 2025 was $2.0 million at TransMedics, up from $1.6 million in the prior quarter.
  • Over five years, Work In Process peaked at $4.9 million in Q3 2024 and troughed at $1.3 million in Q2 2021.
  • A 5-year average of $2.7 million and a median of $2.4 million in 2022 define the central range for Work In Process.
  • Biggest five-year swings in Work In Process: soared 102.88% in 2023 and later crashed 66.52% in 2025.
  • Year by year, Work In Process stood at $1.9 million in 2021, then dropped by 2.9% to $1.9 million in 2022, then soared by 102.88% to $3.8 million in 2023, then decreased by 13.98% to $3.3 million in 2024, then tumbled by 38.73% to $2.0 million in 2025.
  • Business Quant data shows Work In Process for TMDX at $2.0 million in Q4 2025, $1.6 million in Q3 2025, and $3.9 million in Q2 2025.